Objectives: The present study was carried out to evaluate the current prevalence of the clonal group O25b:H4-B2-ST131 among extended-spectrum b-lactamase (ESBL)-producing Escherichia coli (ESBLEC) collected in the Hospital Vall d'Hebron in Barcelona (Spain) with regard to other clonal groups and to characterize their genetic background.
Introduction
The prevalence and epidemiology of extended-spectrum b-lactamase (ESBL)-producing Escherichia coli (ESBLEC) is changing very rapidly. In recent years, ESBL production in E. coli has significantly increased, primarily due to the spread of CTX-M types. 1, 2 Thus, the prevalence of ESBLEC in Spain has increased 8-fold, from 0.5% in 2000 to 4% in 2006. 3 The emergence and dissemination of ESBLEC might have two possible explanations: dissemination of mobile genetic elements between non-clonally related strains, or clonal spread. The two models can occur simultaneously, thereby contributing to the rapid dissemination of ESBLEC. mechanisms of resistance. Thus, b-lactamases other than CTX-M-15, specifically TEM-1, TEM-24, SHV-12, CTX-M-1, -2, -3, -9, -10, -14, -27, -32, -35 and -61, and plasmid-mediated AmpC CMY-2 have also been found to be produced by this clone. 9 -14 Furthermore, CTX-M-15-producing strains of the O25b:H4-B2-ST131 clone often co-produce OXA-1 and TEM-1 b-lactamases as well as aac(6 ′ )-Ib-cr, a variant of an aminoglycoside-modifying enzyme that is responsible for reduced susceptibility both to the aminoglycosides and to certain fluoroquinolones. 8, 9 Due to the important changes that have happened in the epidemiology of ESBLEC during recent years, the aims of the present study were: (i) to analyse the prevalence and distribution of ESBL enzymes in recent years and to perform molecular characterization of the clonal group O25b:H4-B2-ST131 among E. coli isolates recently collected in the Hospital Vall d'Hebron in Barcelona; and (ii) to compare these results with data obtained from the Hospital Xeral-Calde in Lugo 9 (north-west Spain; 1020 km from Barcelona) in order to evaluate the diffusion of the detected clones. Special attention was focused on the detection and characterization of new clonal groups and the distribution of the virulence patterns.
Materials and methods

Bacterial isolates
The present study involved 94 consecutive non-duplicate clinically relevant E. coli isolates positive for ESBL obtained from ambulatory and hospital-admitted patients at Hospital Vall d'Hebron between May and December 2008. Clinical sources included urine (69 isolates), blood (10 isolates), respiratory tract samples (6 isolates), skin samples (5 isolates) and other sources (4 isolates).
Antimicrobial susceptibility and ESBL typing
Susceptibility to b-lactam antibiotics, nalidixic acid, ciprofloxacin, gentamicin, amikacin, tobramycin and co-trimoxazole was determined by disc diffusion, following CLSI recommendations. 15 Suggestive evidence of ESBL production was defined as synergy between amoxicillin/clavulanate and at least one of the following antibiotics: cefotaxime, ceftazidime, aztreonam and cefepime.
To determine the genotype of ESBLs, PCR was performed using the TEM, SHV, CTX-M-1, and CTX-M-9 group-specific primers as reported previously. 16 -18 The resistance genes bla OXA-1 and aac(6 ′ )-Ib-cr were also screened by PCR amplification using specific primers. Sequencing of both strands of amplicons was performed using specific primers. 16 -18 The genetic environment of the bla CTX-M-15 gene was investigated by a PCR specific for upstream insertion elements (ISEcp1 and IS26) in isolates of clone O25b:H4-B2-ST131. 4, 9 Phylogenetic grouping
The phylogenetic group of E. coli isolates (A, B1, B2 and D) was determined by the multiplex PCR-based method of Clermont et al.
19
O and H typing Determination of O and H antigens was carried out using the method previously described by Guinée et al. 20 with all available O (O1 to O181) and H (H1 to H56) antisera. Isolates that did not react with O and H antisera were classified as non-typeable (ONT and HNT), and those that were non-motile were denoted as HNM. Additionally, the specific O25a and O25b molecular subtypes were determined by PCR. 10 
Multilocus sequence typing (MLST)
MLST was performed as previously described by gene amplification and sequencing of the seven housekeeping genes (adk, fumC, gyrB, icd, mdh, purA and recA) according to the protocol and primers specified at the E. coli MLST web site (http://mlst.ucc.ie/mlst/dbs/Ecoli). The allelic profiles of the seven gene sequences and the STs were obtained via the electronic database at the E. coli MLST website. 21 
Virulence factors
The presence of 30 virulence genes was analysed as documented elsewhere, 22 using primers specific for genes and operons that encode extraintestinal virulence factors (VFs) characteristic of extraintestinal pathogenic E. coli (ExPEC): fimH, fimAv MT78 , papEF (positive results were tested for papG I, papG II and papG III alleles), sfa and foc (sfa/focDE were analysed together and positive results were tested for sfaS and focG), afa/draBC, bmaE, gafD, cnf1, cdtB, sat, hlyA, iucD, iroN, kpsM II (establishing neuC-K1, K2 and K5 variants), kpsM III, cvaC, iss, traT, ibeA, malX, usp and tsh. Typing of the afa operon was performed using the seven pairs of primers (for afaE1, afaE2, afaE3, afaE5, afaE7, afaE8 and daaE) designed by Le Bouguénec et al. 23 and the primers recently designed by Blanco et al. 9 for the new afa operon FM955459.
PFGE
XbaI-PFGE analysis was performed as previously described. 22 Profiles were analysed with the BioNumerics fingerprinting software (Applied Maths, St-Martens-Latem, Belgium). Cluster analysis of the Dice similarity indices based on the unweighted pair group method using arithmetic averages (UPGMA) was done to generate a dendrogram describing the relationship among PFGE profiles.
Statistical analysis
Comparisons of proportions and scores were tested using Fisher's exact test. For each comparison, a P value of ,0.05 was considered to denote significant differences.
Results and discussion
Molecular analysis of ESBLs
The most prevalent ESBL types detected among the 94 isolates were CTX-M-14 (46%), CTX-M-15 (26%) and SHV-12 (18%) ( 
Phylogenetic groups
Studies on human E. coli have shown that commensal isolates are characteristically derived from phylogenetic groups A or B1, while the majority of ExPEC isolates are typically assigned to Coelho et al. phylogenetic group B2 and, to a lesser extent, to group D. 22 In the present study, the most common phylogenetic group was B2 (38%), followed by B1 (23%), A and D (19% for each). Interestingly, the majority of CTX-M-15-producing (88%) and SHV-12-producing (56%) isolates belonged to the most virulent group, B2. In contrast, only two (5%) of 44 CTX-M-14-producing isolates derived from this phylogenetic group (P,0.001 for each comparison) ( Table 1 ).
Serotypes and clonal group O25b:H4-B2-ST131
Serotyping of E. coli O and H antigens has appeared to be suitable for identification of the major clonal types of human and animal pathogenic strains. The 94 ESBLEC isolates belonged to 27 O serogroups and 48 different O:H serotypes ( Table 2 ). The most common serotype was O25b:H4 associated with phylogroup B2 and ST131, detected in 19 (79%) of 24 CTX-M-15-producing isolates, in 8 (44%) of 18 SHV-12-producing isolates, in 1 (33%) of 3 CTX-M-9-producing isolates, in 1 (2%) of 44 CTX-M-14-producing isolates and in the 1 CTX-M-27-producing isolate (Tables 1 and 2 ). Thus, in the present study 30 (32%) isolates belonged to clonal group O25b:H4-B2-ST131 (ST131 isolates). In contrast with isolates producing CTX-M-15 and SHV-12, CTX-M-14-producing isolates belonged to a wide variety of serotypes (Table 2) . Similarly, in the Hospital Xeral-Calde in Lugo the most common serotype was O25b:H4, found in 22 (96%) of 23 CTX-M-15 isolates and in 1 (2%) of 60 CTX-M-14 isolates. However, 0 of the 10 SHV-12 isolates obtained in the Lugo study belonged to serotype O25b:H4. 9 In accordance with the present results from Barcelona, the 60 CTX-M-14-producing isolates obtained in Lugo belonged to a wide variety of O:H serotypes, some of which were found in both hospitals (O8:H19, O9:HNM, O15:HNM, O20:H34, O20:HNM, O25b:H4, O78:HNM and ONT:H28). 9 The prevalence of ST131 isolates producing CTX-M-15 in the present study (20%; 19/94) is similar to that found in Lugo (21%; 22/105), 9 and higher than that observed in the GEIH-2006 multicentre study (13%; 32/254). 3 With regard to previous studies, the most interesting result was the identification of eight ST131 isolates producing SHV-12. To our knowledge, only one ST131 isolate producing SHV-12 has been reported previously, by Oteo et al.;
7 this isolate was also detected in Spain, but it was not serotyped or characterized for its virulence genes. According to the significant prevalence of the bla SHV-12 gene previously reported in non-ST131 Spanish E. coli isolates, 3 the novel acquisition of bla SHV-12 by this epidemic clone might have occurred by horizontal transfer from SHV-12-producing non-ST131 E. coli present in the local area.
Antimicrobial resistance and genes bla OXA-1 and aac(6 ′ )-Ib-cr
Eighteen (95%) of the 19 CTX-M-15-producing ST131 isolates harboured bla OXA-1 and aac(6 ′ )-Ib-cr, whereas 0 of the 8 SHV-12-producing ST131 isolates carried these genes (P,0.001). Furthermore, only 5 (8%) and 3 (5%) of the 64 non-ST131 harboured bla OXA-1 and aac(6 ′ )-Ib-cr, respectively. The high prevalence of ST131 isolates carrying the bla CTX-M-15 gene associated with bla OXA-1 and aac(6 ′ )-Ib-cr genes has been reported previously. 7, 9, 24, 25 Eighteen of 19 ST131 isolates carrying bla CTX-M-15 exhibited resistance to both ciprofloxacin and tobramycin, whereas none of the eight SHV-12 producers was resistant to both antimicrobials (P, 0.001) (Figure 1 ). Non-ST131 isolates (%) (n¼64) E. coli O25b:H4-B2-ST131 producing CTX-M-15 and SHV-12
Genetic environment of the bla CTX-M-15 gene
The insertion sequences IS26 and ISEcp1 have been well described previously in the region surrounding bla CTX-M-15 in E. coli and Klebsiella pneumoniae isolates. 4, 6, 26 In our study, an ISEcp1 element was detected upstream of bla CTX-M-15 in all the O25b:H4-B2-ST131 CTX-M-15-producing isolates. In 10 of them, corresponding to the 10 isolates included in group I (Figure 1 , isolates harbouring afa/draBC and kpsMII-K2 genes), an IS26 was found inserted at the end of ISEcp1, separating the bla CTX-M-15 allele from its usual promoter. This clonal cluster is thus highly similar to the epidemic strain A O25-ST131 described in the UK, since both exhibited the same structural organization involving IS26 and ISEcp1, and both carried the afa/dra operon. 4 However, all the isolates (A 1 -A 4 ) of the epidemic strain A from the UK were negative for the kpM II gene. 27 
Virulence factors
ExPEC strains have specialized VFs enabling them to colonize host surfaces, injure host tissues and avoid host defence systems. The 94 ESBLEC isolates in the present study were analysed by PCR for the presence of 30 genes encoding VFs typical of ExPEC that cause urinary tract infections, sepsis and meningitis (Table 3) . Eleven virulence genes (papG III, afaFM955459, cnf1, sat, hlyA, kpsM II-K2, kpsM II-K5, traT, ibeA, malX and usp) were significantly associated with ST131 isolates, whereas papG II and tsh were significantly associated with non-ST131 isolates. Thus, these 11 virulence genes might be important in the worldwide dissemination of the clonal group ST131. In a recent study in the USA, Johnson et al. 28 found that 12 virulence genes (iha, fimH, sat, astA, fyuA, iutA, kpsM II-K2, kpsM II-K5, usp, traT, ompT and malX) were significantly more prevalent among ST131 than among non-ST131 isolates.
A total of 57 (61%) of the 94 ESBL-producing E. coli isolates satisfied criteria for ExPEC status according to the definition of Johnson et al. 29 as they carried two or more of papEF (P fimbriae), sfa/focDE (S/F1C fimbriae), afa/draBC (Dr binding adhesins), iucD (aerobactin receptor) and kpsM II (group 2 capsule synthesis) genes. As expected, phylogroups B2 (92%) and D (89%) were strongly associated with ExPEC status versus A (22%) and B1 (23%) (P,0.001 for each comparison). Accordingly, the prevalence of ExPEC status was higher within ST131 isolates (87%) than within non-ST131 isolates (48%) (P,0.001). Besides, the 30 ST131 isolates exhibited a significantly higher virulence score (mean number of virulence genes 9.60 versus 5.84) compared with the 64 non-ST131 isolates. In particular, the SHV-12-producing ST131 isolates showed the highest virulence score (range 8 -13, mean score 11.75). Figure 1 shows a dendrogram with the XbaI macrorestriction profiles obtained by PFGE of the 30 ST131 isolates that showed a similarity of 66.7%. According to their similarities, the strains remained distributed in five groups (I -V), with identities of 78.1%, 85.7%, 83.3%, 89.8% and 75.7%, respectively. Groups I, III, IV and V were characteristically defined by the virulence profiles of their strains. Group I included 10 ciprofloxacin-, tobramycin-and co-trimoxazole-resistant CTX-M-15 isolates with the same virulence profile that commonly harboured the operon afa/draBC (all positive for afa operon FM955459), sat gene and capsule type K2. Eight of those 10 strains of group I clustered with similarity .85%. Group III included eight CTX-M-14 enzyme encoded by the bla CTX-M-14b gene (GenBank accession number DK359215). 35 Coelho et al. Figure 1 . PFGE of XbaI-digested DNA from the 30 O25b:H4-B2-ST131 isolates included in this study. The dendrogram was generated using the UPGMA algorithm based on the Dice similarity coefficient with 1.0% band position tolerance. Clusters with similarity ≥85% are indicated in bold. Isolate designation, type of ESBL enzyme produced, virulence genes and associated resistances are shown on the right. NAL, nalidixic acid; CIP, ciprofloxacin; SXT, co-trimoxazole; TOB, tobramycin; AMK, amikacin; GEN, gentamicin.
Macrorestriction profiles by PFGE and STs
SHV-12 fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH afa/draBC sat iucD kpsM II-K2 traT malX usp fimH kpsM II-K5 traT malX usp fimH fimAv MT78 sat iucD iroN cvaC iss traT malX usp fimH sat iucD iroN kpsM II-K5 iss traT malX usp fimH sat iucD iroN kpsM II-K5 iss traT malX usp fimH sat iucD iroN kpsM II-K5 iss traT malX usp fimH sat iucD iroN kpsM II-K5 iss traT malX usp fimH papG II sat iucD iroN kpsM II-K5 iss traT malX usp fimH papG II sat iucD iroN kpsM II-K5 iss traT malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH papG III cnf1 hlyA iucD iroN kpsM II-K5 cvaC iss traT ibeA malX usp fimH iucD iroN kpsM II-K1 cvaC iss traT ibeA malX usp tsh fimH iroN kpsM II-K1 iss traT ibeA malX usp fimH iucD iroN kpsM II-K1 cvaC iss traT ibeA malX usp tsh fimH sat iucD iroN kpsM II-K5 iss malX usp fimH sat iucD iroN kpsM II-K5 iss malX usp
CTX-M-15-producing isolates typically positive for sat-iroN-K5-iss genes, with two clusters (similarity .85%) differing in resistance to gentamicin and the presence of the papG II gene. Group IV formed a cluster (similarity .85%) including seven isolates (five SHV-12, one CTX-M-15 and one CTX-M-14) with the same virulence profile, characteristically positive for papGIII-cnf1-hlyA-iroN-K5-cvaC-iss-ibeA genes. Group V included three isolates (two SHV-12 and one CTX-M-9) typically positive for iroN-K1-iss-ibeA genes. In comparison with the study carried out in the hospital at Lugo, a greater genetic diversity within the ST131 clonal group was found, including a great variety of ESBL and virulence genes. In the Lugo study, 76 of 77 ST131 strains were CTX-M-15 producers and all of them clustered together (.85% similarity). Coelho et al. Previously, Nicolas-Chanoine et al., 5 studying the virulence genotypes of 36 CTX-M-15-producing ST131 isolates from eight countries and three continents, found similar pathotypes to those observed in the present study among CTX-M-15-producing isolates of groups I and III. In fact, the similarities shown by strains in both studies were 85.2% for the strains of group I (including 9 of the 10 strains from the present study and 8 from the international study:
5 VB6 and HBS1 from France; and FV7561, FV7563, FV7569, FV7588, FV7593 and FV7595 from Lugo, Spain) and 84.8% for the strains of group III (including the cluster of six papG II-negative strains from the present study and four strains from the international study:
5 MECB5 and VA1 from France; and 15802 and 19502 from Canada) (data not shown).
The novelty of our findings is shown by the strains of group IV; all of them had identical VFs, producing different types of ESBL (CTX-M-14, CTX-M-15 and SHV-12) and clustered with 89.8% similarity. The virulence profile of this cluster had been described previously only in one human ST131 strain, a non-ESBL producer (H2542) isolated in the Lugo hospital in 2009.
14 Besides, the adherent-invasive E. coli strain ST131 (AIEC 13) included in the study of Martinez-Medina et al. 21 carried similar VFs with differences with respect to cdtB (positive) and iss (negative) genes. Comparing the PFGE profiles of both strains with the seven of group IV, the human ST131 strain non-ESBL producer (H2542) formed a cluster of 85.7% similarity with the seven of group IV, and the adherent-invasive E. coli (AIEC 13) showed a similarity of 83.4% with them (data not shown).
Interestingly, we found that the ST131 CTX-M-9-producing strain 81BA isolated in the present study showed the same virulence pattern as the recently emerging clonal group O25b:K1:H4-B2-ST131 ibeA of avian origin reported by Mora et al.
14 Moreover, the strain 81BA of this study showed 100% similarity with the PFGE profile of strain FV14293 isolated from avian meat 14 (data not shown), supporting the conclusion of zoonotic risk for this virulence-specific group.
Non-ST131 isolates that showed similar O and/or H antigens were further analysed by molecular typing (MLST and PFGE) in order to establish their genetic relatedness. As a result, five additional clonal groups including at least two isolates were detected among 16 E. coli producing CTX-M-14 and SHV-12 enzymes: O15/O25a:H1/HNM-D-ST393, O78:HNM-A-ST369, ONT: H21,42/HNM-B1-ST101, O9:H4-A-ST410 and O8:H19-B1-ST162. We found that isolates belonging to the same clonal group exhibited identical or highly similar virulence profiles (Figure 2 
Local epidemiological analysis
Among the 30 ST131 isolates identified in the present study, 21 (70%) were collected from nosocomial infections, including 16 CTX-M-15-producing isolates and 5 SHV-12-producing isolates, and of the remaining 9 isolates, 8 (27%) were collected from community patients and 1 was classified as healthcare associated. Among the 16 isolates belonging to the five other clonal groups detected in the present study (i.e. ST101, ST162, ST393, ST369 and ST410), 15 (94%) were collected from nosocomial infections and the remaining 1 was obtained from a community patient.
In order to establish if these strains spread from patient to patient, data concerning the source of the patient (inpatient or outpatient), dates of hospitalization for the inpatients and isolation dates for each isolate belonging to the detected clonal groups were obtained and compared (data not shown). Regarding ST131 strains, no evidence of any patient-to-patient spread could be found except for two isolates belonging to group IV (36BA and 52BA) that were recovered from two patients hospitalized in the same room in the Neonatology Intensive Care Unit during concurrent periods, suggesting that patient-topatient transmission of the isolates may have occurred. Regarding the non-ST131 clonal groups, patient-to-patient transmission was suspected only in the case of isolates belonging to ST162 (78BA and 86BA) that were recovered from two patients hospitalized in the traumatology unit during concurrent periods. Therefore, despite the high percentage of similarity observed among the isolates included in the PFGE clusters, there was no epidemiological evidence of strain dissemination among patients in 96% of these cases.
Conclusions
In the present study, almost 50% of the ESBLEC (46 of 94) characterized belonged to only six clonal groups. This clonality is very remarkable in E. coli, considering the high genetic diversity of this species, which differs from the established paradigm for the emergence of ESBLs based on the transfer of epidemic resistance-encoding plasmids among non-clonal host bacteria. 5, 34 The main clonal group (ST131) identified in this study, however, showed great genetic diversity, with five different groups according to their virulence, XbaI macrorestriction and resistance patterns. Bearing in mind that the strains were obtained from the same hospital in a very short period of time, this was an unexpected fact.
We report for the first time the spread of a clearly differentiated group of ST131 E. coli isolates producing different types of ESBL enzymes (notably SHV-12), showing a characteristic virulence profile of 13 VFs (notably papG III, cvaC, cnf1 and hlyA) and with highly similar PFGE profiles, indicative of recent emergence.
Future studies are necessary for the understanding of the phylogeny and genetics of ST131, a successful clonal group that combines both resistance and virulence genes, which in classical ExPEC strains have traditionally been mutually exclusive.
